![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1702109
¼öÀÇ ¼ºñ½º ½ÃÀå º¸°í¼ : ¼ºñ½ºº°, µ¿¹° À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°(2025-2033³â)Veterinary Service Market Report by Service (Surgery, Diagnostic Tests and Imaging, Physical Health Monitoring, and Others), Animal Type (Companion Animal, Farm Animal), End Use (Veterinary Clinic, Veterinary Hospital), and Region 2025-2033 |
IMARC GroupÀº ¼öÀÇ ¼ºñ½º ¼¼°è ½ÃÀå ±Ô¸ð°¡ 2024³â 1,182¾ï ´Þ·¯¿¡ ´ÞÇßÀ¸¸ç, 2025-2033³â 4.3%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î 2033³â¿¡´Â 1,729¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ½ÃÀåÀº ¹Ý·Áµ¿¹° »çÀ°·ü Áõ°¡, µ¿¹° °Ç°¿¡ ´ëÇÑ Áö½Ä Çâ»ó, ±â¼ú °³¹ß·Î ÀÎÇØ Áö¼ÓÀûÀ¸·Î °³Ã´µÇ°í ÀÖÀ¸¸ç, ³ôÀº °¡Ã³ºÐ ¼Òµæ°ú ÀÎÇÁ¶óÀÇ ¼±Áø¼ºÀ¸·Î ÀÎÇØ ºÏ¹Ì°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
¼öÀÇ ¼ºñ½º´Â µ¿¹° Áúº´, Àμö°øÅëÀü¿°º´, ½ÄÁßµ¶ÀÇ °¨½Ã, Á¶±â Áø´Ü ¹× Ä¡·á¿¡ ÀÌ¿ëµË´Ï´Ù. µ¿¹° À¯·¡ ½Äǰ ³» µ¿¹°¿ëÀǾàǰÀÇ ÀÜ·ù ¹× Ç×±ÕÁ¦ ³»¼º(AMR) °³¹ß °ü·Ã ±ÔÁ¤ Áؼö À§¹Ý °¡´É¼ºÀ» ÃÖ¼ÒÈÇϱâ À§ÇØ Ç×±ÕÁ¦ µî µ¿¹°¿ëÀǾàǰ¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ´õºÒ¾î ½Äǰ »ý»êÀÚ, °¡°ø¾÷ü, À¯Åë¾÷üÀÇ ÀνÄÀ» Á¦°íÇÏ¿© µ¿¹°¼º ½ÄǰÀÇ ¾ÈÀü¼ºÀ» È®º¸ÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.
µ¿¹°¿¡¼ À¯·¡ÇÑ Àΰ£ º´¿øÃ¼ÀÇ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó µ¿¹° º¸È£, °øÁß º¸°Ç ¹× ½Äǰ ¾ÈÀüÀ» º¸ÀåÇϱâ À§ÇØ ¼öÀÇ ¼ºñ½º°¡ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. ÀÌ´Â Àü ¼¼°èÀûÀ¸·Î ¹Ý·Áµ¿¹° »çÀ°ÀÌ Áõ°¡Çϰí ÀÖ´Â Ãß¼¼¿Í ¸Â¹°·Á ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß Çϳª°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸¹Àº ±¹°¡ÀÇ Á¤ºÎµéÀº Äڷγª¹ÙÀÌ·¯½º°¨¿°Áõ-19(COVID-19)ÀÇ ¹ß»ýÀ» ÀÌÀ¯·Î ¿ø°ÝÀÇ·á¿Í ¼öÀÇ»ç-ȯÀÚ °ü°è(VCPR)¿¡ ´ëÇÑ ±ÔÁ¦¸¦ ¿ÏÈÇÏ¿© ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ ¿ø°ÝÀǷḦ ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï Çã¿ëÇϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á´Â ¼öÀÇÇп¡¼ ¼ö¼ú ÈÄ Á¡°Ë, ÇǺΰúÀû ¹®Á¦, Çൿ ¹®Á¦, ¸¸¼ºÁúȯÀ» °¡Áø ¹Ý·Áµ¿¹°ÀÇ Á¤±âÀûÀÎ °æ°ú °üÂû µî¿¡ Ȱ¿ëµÇ°í ÀÖÀ¸¸ç, À̸¦ ÅëÇØ ¼öÀÇ»ç´Â ¹Ý·Áµ¿¹°À» Á÷Á¢ Áø·áÇÏÁö ¾Ê°íµµ Ä¡·á¸¦ ó¹æÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ´Â ¿Â¶óÀÎ ¹Ý·Áµ¿¹° ¾à±¹, Á¤±â ±¸¸Å ¼ºñ½º¸¦ ÅëÇÑ »ç·á ¹× Á¦Ç° ¹è¼Û µî ÃÖ±Ù ¹Ý·Áµ¿¹° ¼ºñ½ºÀÇ È®´ë¿Í ÇÔ²² ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, Áúº´ ºÎ´ãÀ» ÃÖ¼ÒÈÇÏ°í µ¿¹°ÀÇ °Ç°°ú º¹Áö ¼öÁØÀ» Çâ»ó½Ã۱â À§ÇÑ ¹é½Å, Ç×±ÕÁ¦, Áø´Ü µµ±¸¿Í °°Àº µ¿¹° À§»ý ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ ¹ßÀüÀº ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ãà»ê ºÎ¹®ÀÇ °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀº ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå¿¡ ¹àÀº Àü¸ÁÀ» °¡Á®´Ù ÁÙ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
The global veterinary service market size reached USD 118.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 172.9 Billion by 2033, exhibiting a growth rate (CAGR) of 4.3% during 2025-2033. The market is constantly developing, driven by rising pet ownership, greater knowledge of animal health, and technological developments, with North America leading due to high disposable incomes and advanced infrastructure.
A veterinary service is utilized in the surveillance, early diagnosis, and treatment of animal diseases, zoonoses, and foodborne zoonotic hazards. It relies on veterinary medicinal products, such as antimicrobial agents, to minimize the likelihood of non-compliance concerning veterinary drug residues in food of animal origin and the development of antimicrobial resistance (AMR). Besides this, it assists in increasing awareness about food producers, processors and distributors, and addressing animal production food safety.
With the rising number of human pathogens originating in animals, veterinary services are presently becoming increasingly essential for protecting animals, safeguarding public health, and ensuring food safety. This, in confluence with the increasing adoption of companion animals around the world, represents one of the key factors stimulating the growth of the market. Moreover, governments of numerous countries are relaxing the telemedicine and veterinarian-client-patient relationship (VCPR) regulations on account of the coronavirus disease (COVID-19) outbreak and making telemedicine available to pet parents. It is utilized in veterinary for postoperative checks, dermatologic concerns, behavioral issues, and scheduled follow-up visits for pets with chronic diseases, thereby allowing veterinarians to prescribe the treatment without the direct examination of pets. This, coupled with recent expansions in pet services, including online pet pharmacies and food and product delivery via subscription services, is impelling the market growth. Apart from this, advances in animal health biotechnologies, such as vaccines, antimicrobials, and diagnostic tools, for minimizing the burden of diseases and improving the standards of animal health and welfare are positively influencing the market. In addition, significant growth in the livestock sector is projected to create a positive outlook for the market in the upcoming years.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Addison Biological Laboratory Inc., Armor Animal Health, CityVet, CVS Group PLC, Elanco Animal Health Incorporated, Ethos Veterinary Health LLC, FirstVet, Greencross Vets, Heska Corporation, Idexx Laboratories Inc., Intervet Inc. (Merck & Co. Inc.), PetIQ LLC and Pets at Home Group PLC.